Real-world effectiveness of 6-month tirzepatide therapy on body weight and composition in adults with overweight and obesity.
AIMS/HYPOTHESIS Obesity drives cardiometabolic dysfunction and increases cardiovascular risk, with excess fat mass and impaired body composition playing a key role in metabolic outcomes. This clinical study aimed to evaluate the real-world effectiveness (RWE) of tirzepatide on body weight, body composition, and metabol...